Several single reports or dataset analyses deal with the expression of KIF2C in cervical cancer, nasopharyngeal carcinoma (NPC), laryngeal squamous cell carcinoma (LSCC), laryngeal squamous-cell cancer and bladder cancer [184,200–204]. This evidence concerns the gene KIF2C and urinary bladder carcinoma.